Performance of AMGN Amgen | 10.4% in 12m
Compare AMGN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Amgen with its related Sector/Index XBI
Performance Duell AMGN vs XBI
| TimeFrame | AMGN | XBI |
|---|---|---|
| 1 Day | -0.50% | -1.38% |
| 1 Week | -2.69% | -8.55% |
| 1 Month | -3.01% | -10.19% |
| 3 Months | -13.0% | -4.11% |
| 6 Months | -5.89% | 21.91% |
| 12 Months | 10.4% | 2.66% |
| YTD | -11.0% | -7.48% |
| Rel. Perf. 1m | 0.77 | |
| Rel. Perf. 3m | -1.05 | |
| Rel. Perf. 6m | -2.47 | |
| Rel. Perf. 12m | 0.60 |
Is Amgen a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Amgen is currently (April 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.75 and therefor a neutral outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMGN as of April 2024 is 242.84. This means that AMGN is currently overvalued and has a potential downside of -7.58%.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMGN as of April 2024 is 242.84. This means that AMGN is currently overvalued and has a potential downside of -7.58%.
Is AMGN a buy, sell or hold?
- Strong Buy: 7
- Buy: 5
- Hold: 12
- Sell: 2
- Strong Sell: 2
Values above 0%: AMGN is performing better - Values below 0%: AMGN is underperforming
Compare AMGN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.88% | -0.41% | -22.83% | -11.98% |
| US NASDAQ 100 | QQQ | 2.24% | 0.21% | -22.86% | -23.32% |
| US Dow Jones Industrial 30 | DIA | -0.95% | -0.46% | -19.19% | -2.99% |
| German DAX 40 | DBXD | -1.95% | -2.43% | -23.92% | -1.36% |
| UK FTSE 100 | ISFU | -1.91% | -3.31% | -14.26% | 6.48% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.53% | -1.36% | -6.03% | 27.76% |
| Hongkong Hang Seng | HSI | 3.30% | 5.72% | 5.67% | 37.27% |
| Japan Nikkei 225 | EXX7 | 0.87% | 2.09% | -20.66% | -8.04% |
| India NIFTY 50 | INDA | -0.24% | -3.74% | -21.38% | -17.75% |
| Brasil Bovespa | EWZ | 2.68% | 2.87% | -9.44% | 0.23% |
AMGN Amgen vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.14% | -2.58% | -26.06% | -28.06% |
| Consumer Discretionary | XLY | 2.18% | 1.32% | -14.63% | -6.11% |
| Consumer Staples | XLP | -2.14% | -0.70% | -15.88% | 10.38% |
| Energy | XLE | 1.28% | -5.97% | -9.75% | -1.83% |
| Financial | XLF | -0.79% | -0.47% | -27.12% | -11.16% |
| Health Care | XLV | -0.86% | 1.40% | -13.36% | 5.00% |
| Industrial | XLI | 0.16% | -2.03% | -26.82% | -11.02% |
| Materials | XLB | 0.05% | -1.23% | -22.56% | -0.80% |
| Real Estate | XLRE | 2.33% | 4.81% | -13.64% | 11.31% |
| Technology | XLK | 3.16% | 1.70% | -23.55% | -22.07% |
| Utilities | XLU | -2.30% | -4.92% | -16.62% | 13.63% |
| Aerospace & Defense | XAR | -0.07% | 0.09% | -19.04% | -2.81% |
| Biotech | XBI | 5.86% | 7.18% | -27.80% | 7.70% |
| Homebuilder | XHB | 1.22% | 0.78% | -44.46% | -36.89% |
| Retail | XRT | 1.22% | 3.26% | -23.43% | -4.34% |
Does Amgen outperform its market, is AMGN a Sector Leader?
Yes, over the last 12 months Amgen (AMGN) made 10.36%, while its related Sector, the SPDR S&P Biotech (XBI) made 2.66%.
Over the last 3 months AMGN made -13.03%, while XBI made -4.11%.
Yes, over the last 12 months Amgen (AMGN) made 10.36%, while its related Sector, the SPDR S&P Biotech (XBI) made 2.66%.
Over the last 3 months AMGN made -13.03%, while XBI made -4.11%.
| Period | AMGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.01% | -10.19% | -2.60% |
| 3 Months | -13.03% | -4.11% | 5.16% |
| 12 Months | 10.36% | 2.66% | 22.34% |